<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Molecular Devices LLC valued at $2,163.00 on March 31, 2016. The order is a firm fixed price modification to de-obligate expired lines. Place of performance is Sunnyvale, California. The ultimate completion date is April 30, 2016.</p>
The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Molecular Devices LLC on September 14, 2020, for an ID3 multi-mode microplate detection platform at a ceiling value of $25,000.00. Place of performance is San Jose, California. The order was issued under firm fixed-price terms with an ultimate completion date of September 30, 2020. The procurement was not set-aside and originated from a pre-solicitation opportunity posted on September 13, 2020.
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation for $24,545.41 on August 10, 2016. The order procures various laboratory equipment on a firm fixed price basis. Place of performance is Carlsbad, California. The order is scheduled for completion by September 30, 2016.</p>
The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $7,701 purchase order to Molecular Devices LLC for maintenance services. As a division of Danaher Corporation, Molecular Devices LLC will provide maintenance contract services at its place of performance in Bethesda, Maryland through November 2017. This firm fixed price order was awarded under the HHS-NIH contract vehicle to support the agency's...
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation for $8,880.15 on August 9, 2016. Work was performed in Carlsbad, California. The order was firm fixed price with an ultimate completion date of January 31, 2021. No set-aside was used.</p>
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation valued at $81,885.40 on June 22, 2018, with ultimate completion on December 21, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. The purchase order was a firm fixed price acquisition for scientific instruments, reagents, or consumables typical of Life Technologies' federal supply portfolio supporting research and diagnostic missions.</p>
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Molecular Devices LLC for a SpectraMax ID3 multi-mode microplate detection platform on September 21, 2020, with a ceiling value of $30,343.10. Performance occurs in San Jose, California. The order is firm fixed price with an ultimate completion date of October 20, 2020. The opportunity was posted as a pre-solicitation on September 3, 2020, with a due date of September 8, 2020.</p>
The National Institute of Diabetes and Digestive and Kidney Diseases awarded a $195,419.86 firm-fixed-price purchase order to Molecular Devices LLC for on-site performance assurance of a FLIPR Tetra Lumi 96 instrument located in Bethesda, Maryland. The instrument is used by researchers across the National Institutes of Health for monitoring G protein-coupled receptors and ion channels in drug discovery. The single award non-competitive purchase order was issued under the Department of Health and...
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Thermo Electron North America LLC for $11,578.02 on May 31, 2019. The order, classified as a firm fixed-price purchase order with no set-aside designation, obligated funds for scientific instrumentation or laboratory equipment support. Work is performed in Bethesda, Maryland. The order's ultimate completion date was June 4, 2020.</p>
This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Molecular Devices LLC, a subsidiary of Danaher Corporation. The contract has a ceiling value of $96,433.00 and a completion date of September 30, 2016. Molecular Devices is a leading provider of bioanalytical measurement solutions, including specialized laboratory instruments, equipment,...